A case of ceftriaxone-induced liver injury and literature review.

M. Guarino, Benedetta Perna, Alessandra Pastorelli, Paolo Bertolazzi, G. Caio, M. Maritati, R. De Giorgio, C. Contini
{"title":"A case of ceftriaxone-induced liver injury and literature review.","authors":"M. Guarino, Benedetta Perna, Alessandra Pastorelli, Paolo Bertolazzi, G. Caio, M. Maritati, R. De Giorgio, C. Contini","doi":"10.53854/liim-3002-16","DOIUrl":null,"url":null,"abstract":"Background Liver injury evoked by drugs spans various clinical manifestations ranging from mild biochemical abnormalities to acute liver failure. Ceftriaxone is a third-generation cephalosporin often used in clinical practice for its long half-life, high tissue penetration rate, wide spectrum and good safety profile. Ceftriaxone, as other cephalosporins have little hepatotoxicity; however, few cases of toxic hepatitis induced by this antibiotic have been reported. Case Presentation We describe a case of acute, drug-induced liver injury ('hepatitis') in a 77 years-old female patient treated with ceftriaxone for pneumonia. After 48 hours from antibiotic administration, clinical condition worsened with a clinical and laboratory profile compatible with an acute non cholestatic liver injury. Ceftriaxone administration was immediately stopped and the patient was treated with hydro-electrolyte replacement, high-flow oxygen, vitamin K infusion, steroids and proton-pump inhibitors with a progressive clinical improvement. Conclusions Even if rare, a ceftriaxone-induced hepatotoxicity (confirmed by RUCAM score), should be considered when all other possible causes have been excluded.","PeriodicalId":17977,"journal":{"name":"Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53854/liim-3002-16","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Background Liver injury evoked by drugs spans various clinical manifestations ranging from mild biochemical abnormalities to acute liver failure. Ceftriaxone is a third-generation cephalosporin often used in clinical practice for its long half-life, high tissue penetration rate, wide spectrum and good safety profile. Ceftriaxone, as other cephalosporins have little hepatotoxicity; however, few cases of toxic hepatitis induced by this antibiotic have been reported. Case Presentation We describe a case of acute, drug-induced liver injury ('hepatitis') in a 77 years-old female patient treated with ceftriaxone for pneumonia. After 48 hours from antibiotic administration, clinical condition worsened with a clinical and laboratory profile compatible with an acute non cholestatic liver injury. Ceftriaxone administration was immediately stopped and the patient was treated with hydro-electrolyte replacement, high-flow oxygen, vitamin K infusion, steroids and proton-pump inhibitors with a progressive clinical improvement. Conclusions Even if rare, a ceftriaxone-induced hepatotoxicity (confirmed by RUCAM score), should be considered when all other possible causes have been excluded.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
头孢曲松致肝损伤1例并文献复习。
药物引起的肝损伤具有多种临床表现,从轻度生化异常到急性肝衰竭。头孢曲松是临床常用的第三代头孢菌素,具有半衰期长、组织渗透率高、谱宽、安全性好等优点。头孢曲松和其他头孢菌素一样,几乎没有肝毒性;然而,这种抗生素引起的中毒性肝炎病例很少报道。我们描述了一例急性药物性肝损伤(“肝炎”),患者为77岁女性患者,接受头孢曲松治疗肺炎。停用抗生素48小时后,临床情况恶化,临床和实验室资料符合急性非胆汁淤积性肝损伤。患者立即停用头孢曲松,并给予水电解质替代、高流量供氧、维生素K输注、类固醇和质子泵抑制剂治疗,临床逐渐改善。结论排除所有其他可能的原因后,应考虑头孢曲松所致肝毒性(经RUCAM评分证实)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Real-life use of remdesivir-containing regimens in COVID-19: a retrospective case-control study. The prevalence of gonococcal and non-gonococcal infections in women referred to obstetrics and gynecology clinics. Impact of COVID-19 severity on health-related quality of life among Saudi adult patients. Postbiotics as the key mediators of the gut microbiota-host interactions. Rhino-orbito-cerebral mucormycosis in an acute lymphoblastic leukemia pediatric patient. Case report and review of literature.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1